Binding of the Heterogeneous Ribonucleoprotein K (hnRNP K) to the Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) Enhances Viral LMP2A Expression

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Aug 11

PMID 22879910

Citations 11

Authors

Henrik Gross

Christine Hennard

Ilias Masouris

Christian Cassel

Stephanie Barth

Ute Stober-Grasser

Alfredo Mamiani

Bodo Moritz

Dirk Ostareck

Antje Ostareck-Lederer

Nils Neuenkirchen

Utz Fischer

Wen Deng

Heinrich Leonhardt

Elfriede Noessner

Elisabeth Kremmer

Friedrich A Grasser

Affiliations

Soon will be listed here.

Abstract

The Epstein-Barr Virus (EBV) -encoded EBNA2 protein, which is essential for the in vitro transformation of B-lymphocytes, interferes with cellular processes by binding to proteins via conserved sequence motifs. Its Arginine-Glycine (RG) repeat element contains either symmetrically or asymmetrically di-methylated arginine residues (SDMA and ADMA, respectively). EBNA2 binds via its SDMA-modified RG-repeat to the survival motor neurons protein (SMN) and via the ADMA-RG-repeat to the NP9 protein of the human endogenous retrovirus K (HERV-K (HML-2) Type 1). The hypothesis of this work was that the methylated RG-repeat mimics an epitope shared with cellular proteins that is used for interaction with target structures. With monoclonal antibodies against the modified RG-repeat, we indeed identified cellular homologues that apparently have the same surface structure as methylated EBNA2. With the SDMA-specific antibodies, we precipitated the Sm protein D3 (SmD3) which, like EBNA2, binds via its SDMA-modified RG-repeat to SMN. With the ADMA-specific antibodies, we precipitated the heterogeneous ribonucleoprotein K (hnRNP K). Specific binding of the ADMA- antibody to hnRNP K was demonstrated using E. coli expressed/ADMA-methylated hnRNP K. In addition, we show that EBNA2 and hnRNP K form a complex in EBV- infected B-cells. Finally, hnRNP K, when co-expressed with EBNA2, strongly enhances viral latent membrane protein 2A (LMP2A) expression by an unknown mechanism as we did not detect a direct association of hnRNP K with DNA-bound EBNA2 in gel shift experiments. Our data support the notion that the methylated surface of EBNA2 mimics the surface structure of cellular proteins to interfere with or co-opt their functional properties.

Citing Articles

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.

Baron M, Labreche K, Veyri M, Desire N, Bouzidi A, Seck-Thiam F Haematologica. 2024; 109(11):3615-3630.

PMID: 38841782 PMC: 11532699. DOI: 10.3324/haematol.2023.284332.

Protein Kinase CK2 and Epstein-Barr Virus.

Montenarh M, Grasser F, Gotz C Biomedicines. 2023; 11(2).

PMID: 36830895 PMC: 9953236. DOI: 10.3390/biomedicines11020358.

Methylated HNRNPK acts on RPS19 to regulate ALOX15 synthesis in erythropoiesis.

Naarmann-de Vries I, Senatore R, Moritz B, Marx G, Urlaub H, Niessing D Nucleic Acids Res. 2021; 49(6):3507-3523.

PMID: 33660773 PMC: 8034617. DOI: 10.1093/nar/gkab116.

RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.

Yin Z, Kobayashi M, Hu W, Higashi K, Begum N, Kurokawa K Proc Natl Acad Sci U S A. 2020; 117(21):11624-11635.

PMID: 32385154 PMC: 7261133. DOI: 10.1073/pnas.1921115117.

Post-translational modification control of RNA-binding protein hnRNPK function.

Xu Y, Wu W, Han Q, Wang Y, Li C, Zhang P Open Biol. 2019; 9(3):180239.

PMID: 30836866 PMC: 6451366. DOI: 10.1098/rsob.180239.

References

Jurica M, Moore M . Pre-mRNA splicing: awash in a sea of proteins. Mol Cell. 2003; 12(1):5-14. DOI: 10.1016/s1097-2765(03)00270-3. View

Ling P, Hayward S . Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk. J Virol. 1995; 69(3):1944-50. PMC: 188813. DOI: 10.1128/JVI.69.3.1944-1950.1995. View

Dambacher S, Deng W, Hahn M, Sadic D, Frohlich J, Nuber A . CENP-C facilitates the recruitment of M18BP1 to centromeric chromatin. Nucleus. 2012; 3(1):101-10. PMC: 3337164. DOI: 10.4161/nucl.18955. View

Fuentes-Panana E, Peng R, Brewer G, Tan J, Ling P . Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway. J Virol. 2000; 74(17):8166-75. PMC: 112351. DOI: 10.1128/jvi.74.17.8166-8175.2000. View

Li H, Liu J . Identification of heterogeneous nuclear ribonucleoprotein K as a transactivator for human low density lipoprotein receptor gene transcription. J Biol Chem. 2010; 285(23):17789-97. PMC: 2878543. DOI: 10.1074/jbc.M109.082057. View

Voss M, Hille A, Barth S, Spurk A, Hennrich F, Holzer D . Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter. J Virol. 2001; 75(23):11781-90. PMC: 114764. DOI: 10.1128/JVI.75.23.11781-11790.2001. View

Alfieri C, Birkenbach M, Kieff E . Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 1991; 181(2):595-608. DOI: 10.1016/0042-6822(91)90893-g. View

Bomsztyk K, Denisenko O, Ostrowski J . hnRNP K: one protein multiple processes. Bioessays. 2004; 26(6):629-38. DOI: 10.1002/bies.20048. View

Steinmetz E . Pre-mRNA processing and the CTD of RNA polymerase II: the tail that wags the dog?. Cell. 1997; 89(4):491-4. DOI: 10.1016/s0092-8674(00)80230-5. View

10.

Zhang X, Cheng X . Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure. 2003; 11(5):509-20. PMC: 4030380. DOI: 10.1016/s0969-2126(03)00071-6. View

11.

Naarmann I, Harnisch C, Flach N, Kremmer E, Kuhn H, Ostareck D . mRNA silencing in human erythroid cell maturation: heterogeneous nuclear ribonucleoprotein K controls the expression of its regulator c-Src. J Biol Chem. 2008; 283(26):18461-72. DOI: 10.1074/jbc.M710328200. View

12.

Gary J, Clarke S . RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol. 1998; 61:65-131. DOI: 10.1016/s0079-6603(08)60825-9. View

13.

Crawford D . Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408):461-73. PMC: 1088438. DOI: 10.1098/rstb.2000.0783. View

14.

Grasser F, Haiss P, Gottel S, Mueller-Lantzsch N . Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J Virol. 1991; 65(7):3779-88. PMC: 241408. DOI: 10.1128/JVI.65.7.3779-3788.1991. View

15.

Garcia-Jurado G, Llanes D, Moreno A, Soria B, Tejedo J . Monoclonal antibody that recognizes a domain on heterogeneous nuclear ribonucleoprotein K and PTB-associated splicing factor. Hybridoma (Larchmt). 2011; 30(1):53-9. DOI: 10.1089/hyb.2010.0081. View

16.

Lee J, Sayegh J, Daniel J, Clarke S, Bedford M . PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. J Biol Chem. 2005; 280(38):32890-6. DOI: 10.1074/jbc.M506944200. View

17.

Delecluse H, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W . Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A. 1998; 95(14):8245-50. PMC: 20961. DOI: 10.1073/pnas.95.14.8245. View

18.

Ostareck-Lederer A, Ostareck D, Rucknagel K, Schierhorn A, Moritz B, Huttelmaier S . Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src. J Biol Chem. 2006; 281(16):11115-25. DOI: 10.1074/jbc.M513053200. View

19.

Naarmann I, Harnisch C, Muller-Newen G, Urlaub H, Ostareck-Lederer A, Ostareck D . DDX6 recruits translational silenced human reticulocyte 15-lipoxygenase mRNA to RNP granules. RNA. 2010; 16(11):2189-204. PMC: 2957058. DOI: 10.1261/rna.2211110. View

20.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View